Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27851956)
Watch
English
A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
scientific article
A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALKfusion gene
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
PubMed ID
23181703
retrieved
13 November 2016
case report
0 references
title
A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
(English)
1 reference
stated in
PubMed
PubMed ID
23181703
retrieved
13 November 2016
main subject
adenocarcinoma
1 reference
based on heuristic
inferred from title
author name string
Hisashi Tanaka
series ordinal
1
0 references
Akihito Hayashi
series ordinal
2
0 references
Takeshi Morimoto
series ordinal
3
0 references
Kageaki Taima
series ordinal
4
0 references
Yoshihito Tanaka
series ordinal
5
0 references
Michiko Shimada
series ordinal
6
0 references
Akira Kurose
series ordinal
7
0 references
Shingo Takanashi
series ordinal
8
0 references
Ken Okumura
series ordinal
9
0 references
language of work or name
English
0 references
publication date
26 November 2012
0 references
published in
BMC Cancer
0 references
volume
12
0 references
page(s)
558
0 references
issue
1
0 references
exact match
https://scigraph.springernature.com/pub.10.1186/1471-2407-12-558
0 references
cites work
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515412
retrieved
20 March 2017
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515412
retrieved
20 March 2017
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515412
retrieved
20 March 2017
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515412
retrieved
7 April 2017
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515412
retrieved
7 April 2017
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515412
retrieved
7 April 2017
Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515412
retrieved
29 September 2017
Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515412
retrieved
29 September 2017
Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1186%2F1471-2407-12-558
retrieved
21 January 2018
EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1186%2F1471-2407-12-558
retrieved
21 January 2018
Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23181703
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1186/1471-2407-12-558
1 reference
stated in
PubMed
PubMed ID
23181703
retrieved
13 November 2016
Dimensions Publication ID
1023535411
0 references
PMCID
3515412
1 reference
stated in
PubMed
PubMed ID
23181703
retrieved
13 November 2016
PubMed ID
23181703
1 reference
stated in
PubMed
PubMed ID
23181703
retrieved
13 November 2016
ResearchGate publication ID
233771624
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
